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Background: The aim of this study is to report two interesting cases of cytomegalovirus (CMV) anterior uveitis
following topical prostaglandin analogue administration for glaucoma. Two retrospective case studies are
presented.
Findings: A 40-year-old immunocompetent lady with a history of Fuchs heterochromic iridocyclitis with secondary
glaucoma in the right eye since 2005 was diagnosed to have CMV anterior uveitis by a multiplex polymerase chain
reaction (PCR) in 2009. She developed a reactivation of anterior uveitis following the addition of latanoprost 0.005%
eye drops unknowingly by her local ophthalmologist. The pattern of endothelial deposits seen with this reactivation
of uveitis was different from that seen in earlier or in subsequent reactivations. A 46-year-old immunocompetent
lady with a history of primary open-angle glaucoma and no history of uveitis presented with anterior uveitis with
medium-sized keratic precipitates following administration of travatoprost 0.004% eye drops. In both cases, the CMV
antigen was demonstrated in the aqueous by multiplex PCR at the time of reactivation. Both cases required
treatment with dexamethasone eye drops, ganciclovir 1% gel and oral valganciclovir for the control of
inflammation along with antiglaucoma medications.
Conclusions: We report two immunocompetent cases with the development of CMV-related anterior uveitis
following administration with prostaglandin analogues. These cases increase the awareness of CMV anterior uveitis
in immunocompetent individuals and the need to use prostaglandin analogues with caution.
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Introduction
Topical prostaglandin analogues used to treat glau-
coma are known to cause exacerbations of uveitis [1,2].
Reactivation of herpex simplex keratitis following its
use has been described in the literature [3]. We report
two interesting cases of cytomegalovirus (CMV) anter-
ior uveitis in immunocompetent individuals following
administration of topical prostaglandin analogues. To
our knowledge, this is the first case series of reactiva-
tion of CMV following topical prostaglandin analogues
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A 40-year-old immunocompetent lady initially diagnosed
to have Fuchs heterochromic iridocyclitis with secondary
glaucoma (OD) in 2005 (Figure 1A) had a history of
ocular inflammations with fluctuations in intraocular
pressure (IOP) for which she was using fluorometholone
eye drops (on and off ) and antiglaucoma medications
(betaxolol 0.5% twice a day). In 2009, an aqueous tap done
for persistently high IOP (42 mmHg) showed positive for
CMV antigen by a multiplex PCR and negative for herpes
simplex virus (HSV), varicella zoster virus (VZV), rubella,
chikungunya, toxoplasma and Mycobacterium tuberculosis
(MTb). Serology for CMV IgG was positive but negative
for CMV IgM. A moth-eaten appearance of the iris with no
posterior synechiae, 1 + AC reaction (SUN) and medium-
sized pigmented keratic precipitates located centrally with a
surrounding halo was seen on slit-lamp examination. Theis is an Open Access article distributed under the terms of the Creative
mmons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
inal work is properly cited.
Figure 1 Slit-lamp examination of the right eye of case 1. Showing (A) iris moth-eaten pattern with keratic precipitates located centrally,
(B) pigmented keratic precipitate with a clear halo located centrally in a quiet eye, (C) multiple map-like lesions (arrow) and fine and
medium-sized keratic precipitates on the endothelium following latanoprost 0.005% eye drops and (D) reactivation of anterior uveitis with fine to
medium-sized keratic precipitates post-filtering surgery.
Figure 2 Slit-lamp examination of the right eye of case 2.
Showing inferiorly located medium-sized keratic precipitate after
travoprost 0.004% eye drops.
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(900 mg bid for 3 weeks followed by 450 mg bid for 1
month), dexamethasone eye drops (tapered weekly from an
initial dose of six times a day) and ganciclovir eye gel 0.15%
five times a day. Since then, she has been on a fixed com-
bination of 0.2% brimonidine and 0.5% timolol eye drops
twice a day. In 2010, she was shifted to latanoprost 0.005%
eye drops due to a skin allergy to the above. A quiet eye
with a pigmented central keratic precipitate with a clear
halo and no AC reaction (Figure 1B) was recorded before
starting the drops. She came back with blurring of vision
(OD) 4 days later. Her best-corrected visual acuity (BCVA)
was 6/6 (OU). Slit-lamp examination (OD) showed multiple
map lesions on the endothelium along with fresh, fine and
medium-sized keratic precipitates (Figure 1C) and an IOP
of 50 mmHg. Aqueous tap (OD) was again positive for
CMV antigen by multiplex PCR. Her uveitis and IOP
stabilized with discontinuation of the drug and admin-
istration of dexamethasone eye drops. She eventually
required a filtering surgery. She developed a reactiva-
tion once after the filtering surgery (Figure 1D), which
settled with oral valganiciclovir, dexamethasone eye
drops and ganciclovir gel. At 2 years follow-up, ocular
inflammation and IOP are stable.
Case 2
A 46-year-old immunocompetent lady with a history of
primary open-angle glaucoma (OU) since 2006 presentedwith blurring of vision (OD) after starting travoprost
0.004% eye drops for the right eye a week ago. She had no
history of uveitis. At the time of presentation, her BCVA
was 6/6 (OU). Slit-lamp evaluation (OD) showed medium-
sized keratic precipitates located inferiorly and centrally
(Figure 2) and an IOP of 52 mmHg. Multiplex PCR on the
aqueous tap (OD) showed a positive CMV antigen and
negative for HSV, VZV, rubella, chikungunya, toxoplasma
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for CMV IgM. Her uveitis and IOP settled with discontinu-
ation of travoprost 0.004%, addition of dexamethasone eye
drops and oral valganciclovir (900 mg bid for 3 weeks
followed by 450 mg bid for 1 month). At 6 months
follow-up, her inflammation and IOP are stable.
Discussion
CMV is known to cause anterior uveitis in immunocom-
petent patients [4-6]. Reactivation of CMV anterior uve-
itis has been reported following fluocinolone-sustained
steroid drug delivery implant [4]. Our first case had a
prior history of CMV anterior uveitis and was started on
latanoprost leading to reactivation of anterior uveitis.
The pattern of multiple map-like lesions on the endothe-
lium along with keratic precipitates was seen only during
the reactivation following the prostaglandin analogues
(Figure 1C was different compared to that seen in
Figure 1A,D). The second case did not have a history
of uveitis and developed a CMV anterior uveitis only after
administration of travoprost eye drops. In both cases, the
serology showed increased titres of CMV IgG. We specu-
late that CMV remains latent in the anterior chamber in
some individuals, and this may reactivate when the local
milieu is altered, such as with the administration of pros-
taglandin analogues. Ophthalmologists must be aware of
this presentation of CMV anterior uveitis following usage
of prostaglandin analogues.
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